Earli has an ambitious mission: to force cancer reveal its location at its earliest stages, which makes it quickly treatable. In other words, they aim to make cancer a benign experience. Their science is based on a new method of detecting, localizing and then treating cancer called "Synthetic Biopsies," originally developed by the late Dr. Sam Gambhir at Stanford.

Biotechnology

Earli

Earli's headquarters in South San Francisco, CA, United States

This department oversees project execution and ensures that delivery goals are met efficiently.

Delivery Management

The Advisory Team at Earli plays a critical role in guiding the company’s strategic direction and scientific innovations. Comprised of experienced professionals and experts from various fields, the team provides insights on research and development, market trends, and regulatory landscapes, ensuring that Earli’s Synthetic Biopsies technology aligns with industry standards and advances its mission to detect and localize cancer in its earliest stages.

Advisory Team

The Scientific Research Team at Earli focuses on advancing the innovative method of "Synthetic Biopsies" to enhance early cancer detection and localization. This multidisciplinary team conducts cutting-edge research in molecular imaging, cell biology, and synthetic biology to develop and refine technologies aimed at making cancer diagnosis and treatment more effective and less invasive. Their work plays a critical role in fulfilling Earli's mission to make cancer a more manageable and benign experience.

Scientific Research Team

This department focuses on advancing scientific knowledge and innovative solutions through research and experimentation.

Research and Development

This department oversees the strategic direction and management of CMC-related activities and initiatives.

CMC Leadership

The Leadership Team at Earli is responsible for shaping the company’s strategic direction, overseeing research and development initiatives, and ensuring alignment with the ambitious mission of transforming cancer detection and treatment. Comprising visionary co-founders with expertise in business and science, they drive innovation in Synthetic Biopsies, fostering collaboration and guiding the organization toward its goal of making cancer a manageable condition.

People (2)

Jobs (0)

Other teams

Advisory Team

Scientific Research Team

Research and Development

CMC Leadership

Leadership Team